Close
Nordic 9Nordic 9

Araris Biotech (private company)

Switzerland ararisbiotech.com
See something wrong or missing? Let us know
Offices:Zurich
Industry:Biotech
Business model:B2B

Araris Biotech AG is a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich pioneering a novel antibody-drug conjugate (ADC)-linker technology.

Investors: we tracked 8 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 40.78M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Araris Biotech

Name Criteria
Belgium Aphea.Bio
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Atai Life Sciences
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
United Kingdom Better Dairy
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Biofidelity
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Spain Biome Makers
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
France Core Biogenesis
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Finland Desentum
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Elypta
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top